MARKET

CPIX

CPIX

Cumberland
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.240
-0.090
-2.71%
Closed 16:00 07/02 EDT
OPEN
3.270
PREV CLOSE
3.330
HIGH
3.329
LOW
3.210
VOLUME
12.15K
TURNOVER
--
52 WEEK HIGH
6.39
52 WEEK LOW
3.100
MARKET CAP
49.35M
P/E (TTM)
-9.2943
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CPIX stock price target is 9.75 with a high estimate of 9.75 and a low estimate of 9.75.

EPS

CPIX News

More
All You Need to Know About Cumberland (CPIX) Rating Upgrade to Buy
Zacks · 06/15 17:00
The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week Highs June 3)
Benzinga · 06/04 12:13
Edited Transcript of CPIX earnings conference call or presentation 18-Mar-20 8:30pm GMT
Thomson Reuters StreetEvents · 06/03 16:09
Cumberland Pharmaceuticals: All-Time Lows Look Deserved
Seeking Alpha - Article · 05/28 13:18
Is Cumberland Pharmaceuticals (CPIX) A Good Stock To Buy Now?
Insider Monkey · 05/27 23:00
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday morning, 7 companies hit new 52-week lows.
Benzinga · 05/27 14:44
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26)
Benzinga · 05/27 11:25
33 Stocks Moving in Wednesday's Pre-Market Session
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares rose 47.8% to $1.22 in pre-market trading after jumping over 33% on Tuesday.
Benzinga · 05/27 11:19

Industry

Pharmaceuticals
+0.58%
Pharmaceuticals & Medical Research
+0.61%

Hot Stocks

Symbol
Price
%Change

About CPIX

Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).
More

Webull offers kinds of Cumberland Pharmaceuticals, Inc. stock information, including NASDAQ:CPIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CPIX stock methods without spending real money on the virtual paper trading platform.